TCG Crossover Management »

Korro Bio shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $20M 416k 47.89

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Driehaus Capital Management
FMR
Point72 Asset Management
Cormorant Asset Management
BlackRock
Siren
TCG Crossover Management
Vanguard Group
Qiming U.S. Ventures Management
Tri Locum Partners
72 Investment Holdings
Polar Capital Holdings
Millennium Management

View all funds holding Korro Bio